quinoxalines has been researched along with raltegravir potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breilh, D; Djabarouti, S; Lazaro, E; Mosnier-Thoumas, S; Pellegrin, JL; Saux, MC; Xuereb, F | 1 |
| Butterton, JR; Caro, L; Fandozzi, C; Feng, HP; Fraser, I; Guo, Z; Huang, X; Iwamoto, M; Jumes, P; Ma, J; Mangin, E; Marshall, WL; Panebianco, D; Ross, LL; Talaty, J; Yeh, WW | 1 |
1 trial(s) available for quinoxalines and raltegravir potassium
| Article | Year |
|---|---|
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
Topics: Adult; Amides; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzofurans; Carbamates; Chromatography, Liquid; Coinfection; Cyclopropanes; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Hepatitis C; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Imidazoles; Male; Mass Spectrometry; Middle Aged; Oxazines; Piperazines; Pyridones; Quinoxalines; Raltegravir Potassium; Sulfonamides; Treatment Outcome; Young Adult | 2019 |
1 other study(ies) available for quinoxalines and raltegravir potassium
| Article | Year |
|---|---|
A sensitive liquid chromatography coupled with mass spectrometry method for the intracellular and plasma quantification of raltegravir after solid-phase extraction.
Topics: Adult; Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Female; Humans; Indicators and Reagents; Limit of Detection; Male; Middle Aged; Monocytes; Pyrrolidinones; Quality Control; Quinoxalines; Raltegravir Potassium; Reference Standards; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry | 2011 |